Skip to main content
OpenTrials
Completed

NCT Number: NCT02924844

Impact of the Implementation of a Clinical Pharmacy Bundle on Intensive Care Unit Patient Outcomes and Cost Expenditures

The aim of this before-after study was to assess the impact of a clinical pharmacy bundle of care activities on patient outcomes (length of hospital stay as a primary endpoint) and cost expenditure in two French ICUs.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de Nîmes

Nîmes, Gard, 30029, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Intensive Care Unit patients on weekdays

Treatment and study plan

Primary outcomes

  1. Length of hospital stay

    Time frame: expected average of 20 days

Secondary outcomes

  1. Intensive Care Unit length of stay

    Time frame: Expected maximum of 10 days

  2. Mechanical ventilation duration

    Time frame: Expected maximum of 10 days

  3. Intensive care unit mortality rate

    Time frame: Expected maximum of 10 days

  4. Hospital mortality rate

    Time frame: End of hospital stay (expected average of 20 days)

  5. Patient cost expenditure

    Time frame: End of hospital stay (expected average of 20 days)

Other outcomes

  1. The rate of isolation of multidrug resistant organisms

    Time frame: End of hospital stay (expected average of 20 days)

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nīmes

Other

Registry information

Important dates

Study start
2013
Primary completion
2015
Study completion
2015
First posted
Oct 5, 2016
Registry last updated
Jun 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.